55 results
Page 2 of 3
424B5
c4yy3xj u0uzns
1 Jul 21
Prospectus supplement for primary offering
4:55pm
424B5
cfs5ou dat
28 Jun 21
Prospectus supplement for primary offering
4:02pm
8-K
EX-99.1
1ro2xg58 02cej4wdmzs
19 Oct 20
Intellia Therapeutics Receives Authorization to Initiate Phase 1
8:05am
8-K
EX-99.1
y2mejlzk
5 Oct 20
Intellia Therapeutics Names John F. Crowley to Board of Directors
7:45am
424B5
01dc1geczaaehm
3 Jun 20
Prospectus supplement for primary offering
5:14pm
424B5
ixtamu7w
1 Jun 20
Prospectus supplement for primary offering
4:52pm
8-K
EX-99.1
quub0rlsqd6f6johpzb
7 May 20
Intellia Therapeutics Announces First Quarter 2020 Financial Results
7:47am